Beiley Biofund Inc. (TPEX:7882)
Taiwan · Delayed Price · Currency is TWD 26.70
+0.15 (0.56%)
At close: Sep 24, 2026
Beiley Biofund Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 178.33 | 666.02 | 343.63 | 428.17 |
Short-Term Investments | 621 | 471 | 861 | 561 |
Trading Asset Securities | - | - | 101.66 | 601.15 |
Cash & Short-Term Investments | 799.33 | 1,137 | 1,306 | 1,590 |
Cash Growth | -17.66% | -12.96% | -17.86% | - |
Accounts Receivable | 0.63 | 7.1 | - | - |
Other Receivables | 1.32 | 0.38 | 0.74 | 0.59 |
Receivables | 1.94 | 7.48 | 0.74 | 0.59 |
Other Current Assets | 1.7 | 1.12 | 0.58 | 0.47 |
Total Current Assets | 802.96 | 1,146 | 1,308 | 1,591 |
Property, Plant & Equipment | 5.44 | 5.8 | 2.73 | 2.25 |
Long-Term Investments | 2,158 | 2,277 | 928.98 | 439.54 |
Other Intangible Assets | 0.36 | 0.25 | 0.07 | - |
Other Long-Term Assets | 146.31 | 0.39 | 27.38 | 91.24 |
Total Assets | 3,113 | 3,429 | 2,267 | 2,124 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accrued Expenses | 45.4 | 69.25 | 33.33 | 0.06 |
Current Portion of Leases | 1.02 | 1 | 1.06 | 1.04 |
Current Income Taxes Payable | 31.91 | 37.81 | 13.62 | - |
Other Current Liabilities | 289.47 | 3.29 | 0.48 | 0.48 |
Total Current Liabilities | 367.79 | 111.34 | 48.49 | 1.57 |
Long-Term Leases | 3.95 | 4.46 | - | 1.06 |
Long-Term Deferred Tax Liabilities | - | 0.03 | - | - |
Total Liabilities | 371.73 | 115.84 | 48.49 | 2.63 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 2,053 | 2,053 | 2,053 | 2,000 |
Additional Paid-In Capital | 6.28 | 6.28 | 6.28 | 6.28 |
Retained Earnings | 610.07 | 1,254 | 159.18 | 115.4 |
Shareholders' Equity | 2,741 | 3,313 | 2,218 | 2,122 |
Total Liabilities & Equity | 3,113 | 3,429 | 2,267 | 2,124 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 4.96 | 5.46 | 1.06 | 2.09 |
Net Cash (Debt) | 794.36 | 1,132 | 1,305 | 1,588 |
Net Cash Growth | -18.13% | -13.30% | -17.82% | - |
Net Cash Per Share | 3.74 | 5.32 | 6.14 | 16.98 |
Filing Date Shares Outstanding | 212.47 | 212.47 | 212.47 | 93.54 |
Total Common Shares Outstanding | 212.47 | 212.47 | 212.47 | 93.54 |
Working Capital | 435.18 | 1,034 | 1,259 | 1,590 |
Book Value Per Share | 12.90 | 15.59 | 10.44 | 22.68 |
Tangible Book Value | 2,741 | 3,313 | 2,218 | 2,122 |
Tangible Book Value Per Share | 12.90 | 15.59 | 10.44 | 22.68 |
Machinery | 0.99 | 0.66 | 0.58 | 0.16 |
Leasehold Improvements | 1.91 | 1.91 | 1.91 | - |